The inhibition of bovine heart hexokinase by 2-deoxy-D-glucose-6-phosphate: characterization by 31P NMR and metabolic implications
- PMID: 1467345
- DOI: 10.1016/0300-9084(92)90070-u
The inhibition of bovine heart hexokinase by 2-deoxy-D-glucose-6-phosphate: characterization by 31P NMR and metabolic implications
Abstract
The glucose analog, 2-deoxy-D-glucose (2DG), has been used widely for studying the initial steps in the metabolism of glucose by radio-isotope tracer methods and by 31P NMR. In the rat heart perfused with acetate/2DG (both 5 mM) plus insulin, trapping of phosphorus by 2-deoxy-D-glucose-6-phosphate (2DG6P) results in a steady state exhibiting high 2DG6P (55 mM) and low ATP concentrations but near-normal function, as observed in an earlier 31P NMR study. In order to understand how the 2DG6P concentration is stabilized, we studied the inhibition of a mammalian hexokinase by 2DG6P in vitro by a 31P NMR technique. Inhibition, previously unobserved, was found. It is similar to inhibition by G6P in that it is competitive with ATP and not competitive with 2DG, but the inhibition constant (1.4 mM) is much larger. The experimental protocol includes provisions for enzymatic destruction of stray inhibitors such as G6P. The results show that the high 2DG6P and low ATP concentrations found in the steady state of the perfused heart should strongly reduce the rate of phosphorylation of sugars by hexokinase.
Similar articles
-
Insulin increases the rate of degradation of 2-deoxy-glucose-6-phosphate in the perfused rat heart: a 31P NMR study.J Mol Cell Cardiol. 1991 Oct;23(10):1101-15. doi: 10.1016/0022-2828(91)90200-6. J Mol Cell Cardiol. 1991. PMID: 1749002
-
Accumulation of 2-deoxy-D-glucose-6-phosphate as a measure of glucose uptake in the isolated perfused heart: a 31P NMR study.Metab Eng. 2004 Jan;6(1):36-43. doi: 10.1016/j.ymben.2003.10.002. Metab Eng. 2004. PMID: 14734254
-
The Action of the Hexokinase Inhibitor 2-deoxy-d-glucose on Cryptosporidium parvum and the Discovery of Activities against the Parasite Hexokinase from Marketed Drugs.J Eukaryot Microbiol. 2019 May;66(3):460-468. doi: 10.1111/jeu.12690. Epub 2018 Oct 5. J Eukaryot Microbiol. 2019. PMID: 30222231 Free PMC article.
-
2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents.Int J Mol Sci. 2019 Dec 29;21(1):234. doi: 10.3390/ijms21010234. Int J Mol Sci. 2019. PMID: 31905745 Free PMC article. Review.
-
Hypothesis: A Novel Neuroprotective Role for Glucose-6-phosphatase (G6PC3) in Brain-To Maintain Energy-Dependent Functions Including Cognitive Processes.Neurochem Res. 2020 Nov;45(11):2529-2552. doi: 10.1007/s11064-020-03113-z. Epub 2020 Aug 19. Neurochem Res. 2020. PMID: 32815045 Review.
Cited by
-
Metabolic Plasticity and Combinatorial Radiosensitisation Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck Cell Lines.Cancers (Basel). 2021 Sep 28;13(19):4836. doi: 10.3390/cancers13194836. Cancers (Basel). 2021. PMID: 34638320 Free PMC article.
-
Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation.J Biol Chem. 2015 Oct 16;290(42):25427-38. doi: 10.1074/jbc.M115.646984. Epub 2015 Aug 28. J Biol Chem. 2015. PMID: 26318453 Free PMC article.
-
A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth.Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17807-11. doi: 10.1073/pnas.0803090105. Epub 2008 Nov 11. Proc Natl Acad Sci U S A. 2008. PMID: 19004802 Free PMC article.
-
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor.Cells. 2021 Feb 18;10(2):431. doi: 10.3390/cells10020431. Cells. 2021. PMID: 33670598 Free PMC article.
-
Targeting Glucose Metabolism Sensitizes Pancreatic Cancer to MEK Inhibition.Cancer Res. 2021 Aug 1;81(15):4054-4065. doi: 10.1158/0008-5472.CAN-20-3792. Epub 2021 Jun 11. Cancer Res. 2021. PMID: 34117030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
